ALPS Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $919K | Sell |
22,678
-5,158
| -19% | -$209K | 0.01% | 517 |
|
|
2025
Q1 | $1.43M | Sell |
27,836
-3,070
| -10% | -$158K | 0.01% | 401 |
|
|
2024
Q4 | $1.71M | Buy |
30,906
+1,664
| +6% | +$92.1K | 0.01% | 365 |
|
|
2024
Q3 | $962K | Sell |
29,242
-226
| -0.8% | -$7.43K | 0.01% | 498 |
|
|
2024
Q2 | $801K | Buy |
29,468
+3,020
| +11% | +$82.1K | 0.01% | 511 |
|
|
2024
Q1 | $961K | Buy |
26,448
+4,621
| +21% | +$168K | 0.01% | 496 |
|
|
2023
Q4 | $442K | Sell |
21,827
-2,278
| -9% | -$46.1K | ﹤0.01% | 625 |
|
|
2023
Q3 | $428K | Buy |
24,105
+4,404
| +22% | +$78.3K | ﹤0.01% | 618 |
|
|
2023
Q2 | $356K | Buy |
19,701
+2,132
| +12% | +$38.5K | ﹤0.01% | 713 |
|
|
2023
Q1 | $221K | Sell |
17,569
-507
| -3% | -$6.37K | ﹤0.01% | 974 |
|
|
2022
Q4 | $265K | Buy |
+18,076
| New | +$265K | ﹤0.01% | 940 |
|